Login / Signup
Michael E Stokes
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 2
Top Topics
Renal Cell Carcinoma
Endoplasmic Reticulum
Pain Management
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Veronica Calvo
,
Wei Zheng
,
Anna Adam-Artigues
,
Kirk A Staschke
,
Xin Huang
,
Julie F Cheung
,
Ana Rita Nobre
,
Sho Fujisawa
,
David Liu
,
Maria Fumagalli
,
David Surguladze
,
Michael E Stokes
,
Ari Nowacek
,
Mark J Mulvihill
,
Eduardo F Farias
,
Julio A Aguirre-Ghiso
A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer Cells.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)
Michael E Stokes
,
Veronica Calvo
,
Sho Fujisawa
,
Crissy Dudgeon
,
Sharon Huang
,
Nupur Ballal
,
Leyi Shen
,
Jennifer Gasparek
,
Matthew Betzenhauser
,
Simon J Taylor
,
Kirk A Staschke
,
Alan C Rigby
,
Mark J Mulvihill
,
Nandita Bose
,
Eric S Lightcap
,
David Surguladze
PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase Inhibitors.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)